What you'll be doing
.
The Clinical Nurse Specialist Grade 2 (CNS2) provides a conduit to facilitate information sharing, planned care and care coordination for patients within the hospital and the continuum through liaising and networking with key stakeholders both internal and external. The CNS2 is an expert in their area of speciality who provides leadership, advice and recommendations on all aspects of related care. The CNS2 formulates and implements policy, guides practice, and engages in education and research activities. The CNS2 acts as a role model providing complex care to those patients requiring advanced clinical skills regarding their area of specialty.
The aim of the Substance use in Pregnancy and Parenting Service is to provide coordinated, collaborative and client centred care to women who use substances and are pregnant and/or are the parents of children under the age of 2. The desired outcome being a reduction in the social, emotional and physical impact on women, children and families. The Substance Use in Pregnancy and Parenting Service also aims to build the capacity of health service providers to identify, respond, and engage substance using parents in health care. The Substance Use in Pregnancy and Parenting D&A Consultation and Liaison Nurse provides consultancy and comprehensive Drug and Alcohol assessment, clinical treatment, psycho-educational interventions and referral processes in accordance with relevant drug and alcohol guidelines and best practice standards.
Candidates will need to meet the following criteria:
1. Division 1 Registered Nurse with relevant post registration qualifications and at least 3 years’ experience working in the clinical area of their specified post-graduate qualifications or such other qualifications or relevant equivalent experience.
2. Proven clinical leadership skills and an ability to work collaboratively within a multidisciplinary framework with a demonstrated commitment to excellence in nursing practice.
3. High level clinical skills in D&A assessment, withdrawal, opioid and other pharmacotherapies, psychosocial interventions, and treatment planning for patients with complex presentations.
Applications Close: 5 February 2024